References

  1. Kane MA. Global program for control of Hepatitis B infection. Vaccine. 1995;13 Suppl 1:S47-9. PubMed | Google Scholar

  2. de Franchis R, Hadengue A, Lau G, Lavanchy D, et al. EASL International Consensus Conference on Hepatitis B. 13-14 September, 2002 Geneva, Switzerland. Consensus statement (long version). J Hepatol. 2003;39 Suppl 1:S3-25. PubMed | Google Scholar

  3. Ndumbe PM. Epidémiologie de l’hépatite B. Département de microbiologie et des pathologies infectieuses, Faculté de médecine et de sciences biomédicales, Université de Yaoundé I, BP 8445, Yaoundé, Cameroun. Google Scholar

  4. Barbare JC. Déclaration de Rabbat. Cancero dig. 2009; 1(2): 104-106. PubMed | Google Scholar

  5. Byrne EB. Viral hepatitis : on occupational hazard of medical personnel- Experience of the Yale-New Haven Hospital, 1952-196 JAMA. 1966 Jan 31;195(5):362-4. PubMed | Google Scholar

  6. Needlestick-prevention devices. Health Devices. 1999 Oct;28(10):381-408. PubMed | Google Scholar

  7. Noah Noah D, Njouom R, Bonny A, Pirsou, Meli J, Biwole Sida M. HBs antigene prevalence in blood donors and the risk of transfusion of hepatitis B at the central hospital of Yaounde, Cameroon. Open journal of gastroenterology. 2011; 1: 23-2. PubMed | Google Scholar

  8. Foupouapouognigni Y, Mba SA, Betsem à Betsem E, Rousset D, et al. Hepatitis B and C Virus Infections in the pygmy Groups in Cameroun. J Clin Microbiol. 2011 Feb;49(2):737-40. PubMed | Google Scholar

  9. Francis D, Hadler S, Thompson S et al. The prevention of hepatitis B with vaccine: report of the Center for Disease Control Multi-Center Efficacy Trial among homosexual men. Ann Intern Med. 1982 Sep;97(3):362-6. PubMed | Google Scholar

  10. Chang M, Chen C, Lai M et al. Universal Hepatitis B vaccination in Taiwan and the incidence of hepatocellular carcinoma in children. N Engl J Med. 1997 Jun 26;336(26):1855-9. PubMed | Google Scholar

  11. Kao J, Hsu H, Shau W, Chang M, Chen D. Universal hepatitis B vaccination and the decreased mortality from fulminant hepatitis in infants in Taiwan. J Pediatr. 2001 Sep;139(3):349-52. PubMed | Google Scholar

  12. Begue P, Chen R, Costagliola, Delarocque-Astagneau E, Denis F, et al. Réunion de consensus : vaccination contre l’hépatite B ; 10 et 11 septembre 2003 : INSERM ANAES Paris. Google Scholar

  13. Ibekwe RC, Ibeziako K. Hepatitis B vaccination status among health workers in Enugu, Nigeria. Niger J Clin Pract. 2006 Jun; 9(1):7-10. PubMed | Google Scholar

  14. Braka F, Nanyunja M, Makumbi I, Mbabazi W, Kasasa S, Lewis R. Hepatitis B infection among health workers in Uganda: Evidence of the need for health worker protection. Vaccine. 2006 Nov 17; 24(47-48):6930-7. PubMed | Google Scholar

  15. Djeriri K, Laurichesse H, Merle JL, et al. Hepatitis B in Morocan health care workers. Occup Med (Lond). 2008 Sep;58(6):419-24. PubMed | Google Scholar

  16. Pietra V, Kiema D, Sorgho D et al. Prévalence des marqueurs du virus de l'hépatite B et des anticorps contre le virus de l'hépatite C parmi le personnel de district sanitaire de Nanoro, Burkina Faso. Science et technique, Science et Santé. 2008 Déc 31; 1(2):53-9. PubMed | Google Scholar

  17. Ciorlia LA, Zanetta DM. Hepatitis B in healthcare workers: prevalence, vaccination and relation to occupational factors. Braz J Infect Dis. 2005 Oct;9(5):384-9. PubMed | Google Scholar